Reactions Weekly

, Volume 1213, Issue 1, pp 2–2 | Cite as

The risk of developing cancer is not increased among patients who received contaminated Viracept [nelfinavir]

Media release
  • 8 Downloads

Keywords

Public Health Ethyl Marketing Specific Patient Viracept 

REFERENCE

  1. 1.
    EMEA.Studies assessed by the EMEA indicate no increased risk of developing cancer for patients who have taken Viracept contaminated with ethyl mesilate. Media Release: 24 Jul 2008. Available from: URL: http://www.emea.europa.eu

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations